Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 13;14:393–402. doi: 10.2147/OTT.S270149

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Qin et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

PCED1B-AS1 played a carcinogenic role in ccRCC cells through the miR-484/ZEB1 axis. miR-484 inhibitors or NC inhibitors were co-transfected into A498 and Caki-1 cells with PCED1B-AS1 silenced. (A) qRT-PCR was employed to detect miR-484 expression. (B) Western blotting was used to detect ZEB1 protein expression. (C, D) CCK-8 and EdU were used to detect the proliferation of A498 and Caki-1 cells. (E) Wound healing test was used to detect the migration of A498 and Caki-1 cells. (F) Western blotting was used to detect the expression level of EMT-related proteins. *P < 0.05, **P < 0.01, and ***P < 0.001.